The Committee calls once more for a clear commitment from the Scottish Government that it will use its chosen method of mitigating the effects of the bedroom tax - Discretionary Housing Payments or DHPs -- to mitigate all the financial impact of the bedroom tax, both past and present, on tenants in Scotland. The Government confirmed in a letter to the Committee, from David Mundell MP, that Scottish Ministers will be allowed to set the statutory cap on DHPs in Scotland, allowing them to increase the amount paid through DHPs to cover all of the loss caused by the bedroom tax if they choose to. The Committee welcomes this, and the Scottish Government's commitment to make additional funding available for mitigation. The Committee says both Governments should expedite the necessary procedures which will enable the Scottish Government to lift the cap on DHPs in Scotland as quickly as possible.

The Scottish Government's plan to negate the future effects of the bedroom tax in Scotland is inadequate, and further that the route they have identified - using Discretionary Housing Payments (DHPs) - is flawed. The Committee has taken evidence in Scotland and Westminster on the impacts of the bedroom tax but also on the best and most effective ways of mitigating those effects. The Committee reiterates its call for the Scottish Government to meet all the bedroom tax charges for Scottish tenants, write off all the arrears, and refund all the payments that have been made, as the only fair and workable way forward.

This second editionis a ground-breaking clinical text with a strong emphasis on rigorous evidence. Leaders in the field discuss best practice in the light of systematic reviews and randomised control trials, and how best to treat where the information is less clear. Case histories provide intriguing discussions on how to apply the evidence in real life situations. Evidence-based Cardiology also includes free access to the latest evidence, which is automatically posted on a companion website.

Although primarily used today as one of the most prevalent illicit leisure drugs, the use of Cannabis sativa L., commonly referred to as marijuana, for medicinal purposes has been reported for more than 5000 years. Marijuana use has been shown to create numerous health problems, and, consequently, the expanding use beyond medical purposes into recreational use (abuse) resulted in control of the drug through international treaties. Much research has been carried out over the past few decades following the identification of the chemical structure of THC in 1964. The purpose of Marijuana and the Cannabinoids is to present in a single volume the comprehensive knowledge and experience of renowned researchers and scientists. Each chapter is written independently by an expert in his/her field of endeavor, ranging from the botany, the constituents, the chemistry and pharmacokinetics, the effects and consequences of illicit use on the human body, to the therapeutic potential of the cannabinoids.

"Malathion is a registered insecticide and acaricide used on a wide variety of sites including agricultural and non-agricultural sites. In 2018 (the most recent year for which data are available), over 25 000 kg of malathion was sold in Canada. Malathion may be released into surface water or soil as runoff from the application site. Malathion is not usually found in drinking water sources in Canada. Low levels of malathion have been found in several Canadian provinces. The maximum reported concentrations are well below the MAC. Malathion is rarely detected in foods"--Executive summary.

At the last Annual Representative Meeting of the British Medical Association a motion was passed that `certain additional cannabinoids should be legalized for wider medicinal use.'' This report supports this landmark statement by reviewing the scientific evidence for the therapeutic use of cannabinoids and sets the agenda for change. It will be welcomed by those who believe that cannabinoids can be used in medical treatment. The report discusses in a clear and readable form the use and adverse effects of the drug for nausea, multiple sclerosis, pain, epilepsy, glaucoma, and asthma.

Indentifies, for recreational water use, risks from exposure to fecal streptococci and other micro-organisms. Deals also with pH, nuisance organisms, temperature, aesthetics, and turbidity. Includes a section on sampling and enumeration of indicators of recreational water quality.